Medthority Profile Banner
Medthority Profile
Medthority

@Medthority

Followers
3K
Following
592
Media
2K
Statuses
6K

Get closer to the conversations that matter in medicine, with our award-winning medical education platform. https://t.co/b7oE8RLHkt

Europe / Global
Joined April 2009
Don't wanna be here? Send us removal request.
@Medthority
Medthority
9 hours
In honour of #WorldBreastCancerResearchDay, we’re highlighting our expert resources on breast cancer management. From podcast series and webinars to infographics and guideline recommendations, get insights on CDK4/6 inhibitors in breast cancer care #MedX.
Tweet media one
0
0
0
@Medthority
Medthority
1 day
Which diagnostic tools should you use for #NMIBC, and when? Tune in to our NEW podcast series, hosted by @UroDocAsh, for actionable insights on managing NMIBC diagnosis and implementing clinical guidelines into your practice #MedX #BladderCancer.
Tweet media one
0
0
0
@Medthority
Medthority
2 days
Which drug shows early therapeutic benefit in generalized myasthenia gravis (gMG) according to new data? Get closer to the conversations that matter with our latest article on reduced symptom severity and enhanced quality of life #MedX #MG #Neurology.
Tweet media one
0
0
0
@Medthority
Medthority
5 days
What would people with AA like healthcare professionals to do differently when discussing AA management? Watch patient advocate and @AlopeciaUK Trustee Lynn Wilks talk about her lived experience and how patient-doctor interactions could improve #MedX .
0
0
0
@Medthority
Medthority
6 days
What are the first steps when diagnosing secondary #HLH/MAS? Swipe through for a breakdown of diagnostic criteria and click the link below for insights on clinical features, assessment tools, and comorbidities #MedX #Rheumatology #Hematology #Diagnosis.
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
0
0
@Medthority
Medthority
7 days
How can a patient-centric approach transform outcomes in #CIDP? Watch our NEW expert interview with Eduardo Nobile-Orazio as he shares practical insights on early symptom recognition, personalizing treatment, and exploring future therapies #MedX.
Tweet media one
0
0
0
@Medthority
Medthority
8 days
Could a promising new therapy fill the gap in treatment options available for children with #alopecia areata (#AA)? Read our latest article on a novel botanical agent showing quality of life benefits and improved patient outcomes in pediatric AA #MedX .
Tweet media one
0
0
0
@Medthority
Medthority
9 days
August is #PsoriasisActionMonth! Visit Medthority now for a range of expert dermatology resources, from our Psoriasis Academy to our on-demand roundtable on biologics in plaque psoriasis, chaired by Luis Puig #MedX #Dermatology #Psoriasis.
Tweet media one
0
0
0
@Medthority
Medthority
12 days
New data suggests chronic spontaneous urticaria (#CSU) isn’t just skin deep. Read our latest article now for insights on the severe itch associated with this disease, and the link to reduced quality of life for patients #MedX #Dermatology #MedicalNews.
Tweet media one
0
0
0
@Medthority
Medthority
13 days
How are patient insights reshaping disease management and research priorities in #LOPD? Watch this accredited symposium recording for insights on the multisystemic nature of LOPD beyond muscle weakness, plus strategies for multidisciplinary care #MedX.
Tweet media one
0
0
0
@Medthority
Medthority
14 days
Did you know you can access the latest clinical guidelines and pivotal trial data shaping #prostatecancer care on our Prostate Cancer Nexus? Get the insights you need to know on evolving standards and evidence-based strategies at the link below #MedX.
Tweet media one
0
0
0
@Medthority
Medthority
15 days
Which emerging therapies for non-muscle-invasive bladder cancer (#NMIBC) could shift the treatment landscape? Catch up with key highlights from #ASCO2025 for the latest updates on the future of NMIBC care, on demand with Medthority #MedX #ASCO .
Tweet media one
0
0
0
@Medthority
Medthority
16 days
What is #AATD, and how does it impact the liver and lung? Tune in to our accredited podcast series, Understanding AATD, now for insights from Pavel Strnad and @MiravitllesMarc, plus listen to all 4 episodes to earn 1.5 #CME credits #MedX #LiverDisease.
Tweet media one
0
0
0
@Medthority
Medthority
19 days
How do you diagnose HLH/MAS when biologics blur the lines? Tune in to episode 2 of our expert podcast series, Unveiling HLH/MAS, to hear Michael Jordan and Francesca Minoia discuss the complexities of diagnosing hyperinflammation with precision #MedX.
Tweet media one
0
0
0
@Medthority
Medthority
20 days
New insights on #CIDP diagnosis! Read our latest article summarising recent findings on the use of imaging technologies in identifying CIDP, providing a new approach for clinicians navigating atypical presentations #MedX #MedNews.
Tweet media one
0
0
0
@Medthority
Medthority
21 days
What unmet needs matter most to people living with #alopecia areata (#AA)? Lynn Wilks, patient advocate and @AlopeciaUK Trustee, shares her personal account of day-to-day life with AA and the improvements she’d like to see in current practice #MedX.
Tweet media one
0
0
0
@Medthority
Medthority
21 days
What's new in TK2d? Watch this accredited symposium recording from #EPNS2025 for insights from Cristina Domínguez González, Caterina Garone, and Michio Hirano on early detection and emerging therapies . #CME #MedEd .
Tweet media one
0
0
0
@Medthority
Medthority
23 days
Notice anything different? Medthority has a new look! Get closer to the conversations that matter in medicine with the trusted scientific updates you need to know, now with a fresh, updated design. Take a look and let us know what you think! #MedEd #MedX.
Tweet media one
0
0
0
@Medthority
Medthority
26 days
How much do you know about overlooked symptoms and unmet needs in #LOPD? Don't miss your chance to earn #CME credit today with this on-demand symposium recording, featuring expert perspectives on new patient data #MedX .
Tweet media one
0
0
1
@Medthority
Medthority
27 days
How long do you monitor prostate-specific antigen (PSA) levels for after radical prostatectomy (RP)? Read about a new study that suggests monitoring PSA levels for longer than commonly practiced to avoid overtreatment in #prostatecancer care #MedX.
Tweet media one
0
0
0